Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NETILDEX ophthalmic gel twice daily versus eye drops four times daily after cataract surgery
2016-002138-63Phase 3Completed
- Sponsor
- SIFI SpA
- Start
- Feb 2018
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, RNA-Targeting Small Molecules → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of netilmicin + dexamethasone in Postoperative ocular inflammation, eye infection, sponsored by SIFI SpA. Started Feb 2018; status: completed.
02
Drugs
netilmicin + dexamethasone
03
Conditions
Postoperative ocular inflammationeye infection
Beyond the preview
Go deeper on 2016-002138-63.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2016-002138-63.